(Q37691776)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20153159%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

review article

1 reference

title

Regulatory T cells in transplantation: does extracellular adenosine triphosphate metabolism through CD39 play a crucial role? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20153159%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

main subject

adenosine triphosphate

0 references

author

Francisco Salcido-Ochoa

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20153159%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Paul Kwong Hang Tam

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20153159%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

5

Olaf Rotzschke

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20153159%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

Julia Tsang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20153159%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Kirsten Falk

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20153159%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

publication date

11 February 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20153159%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

published in

Transplantation Reviews

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20153159%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20153159%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20153159%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

52-66

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20153159%20AND%20SRC:MED&resulttype=core&format=json

Kidney and pancreas transplantation in the United States, 1995-2004.

18 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Chronic renal allograft dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Why hasn't eliminating acute rejection improved graft survival?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Immunology taught by viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Control of neonatal tolerance to tissue antigens by peripheral T cell trafficking

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Major histocompatibility complex class I-restricted cross-presentation is biased towards high dose antigens and those released during cellular destruction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Levels of peripheral T cell tolerance induced by different doses of tolerogen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8(+) T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Th17: the third member of the effector T cell trilogy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Immobilized anti-CD3 mAb induces anergy in murine naive and memory CD4+ T cells in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Anergic T cells act as suppressor cells in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Do suppressor T cells exist?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Saying the 'S' word in public.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

"Infectious" transplantation tolerance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Specific suppression of T helper alloreactivity by allo-MHC class I-restricted CD8+CD28- T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

In vitro and in vivo analysis of bone marrow-derived CD3+, CD4-, CD8-, NK1.1+ cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Identification of a previously unknown antigen-specific regulatory T cell and its mechanism of suppression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

The mucosal milieu creates tolerogenic dendritic cells and T(R)1 and T(H)3 regulatory cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Essential roles of CD8+CD122+ regulatory T cells in the maintenance of T cell homeostasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

The specific regulation of immune responses by CD8+ T cells restricted by the MHC class Ib molecule, Qa-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Induction of TCR Vbeta-specific CD8+ CTLs by TCR Vbeta-derived peptides bound to HLA-E.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Isolation and characterization of human antigen-specific TCR alpha beta+ CD4(-)CD8- double-negative regulatory T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Tolerization of dendritic cells by T(S) cells: the crucial role of inhibitory receptors ILT3 and ILT4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Dysfunctional blood and target tissue CD4+CD25high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Functional defect of regulatory CD4(+)CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Anti-TNF-alpha therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-beta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Establishment of tissue-specific tolerance is driven by regulatory T cells selected by thymic epithelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Major histocompatibility complex class II-positive cortical epithelium mediates the selection of CD4(+)25(+) immunoregulatory T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Regulatory CD4 T cells: expression of IL-2R alpha chain, resistance to clonal deletion and IL-2 dependency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rbeta-deficient mice. Implications for the nonredundant function of IL-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

A critical function for TGF-beta signaling in the development of natural CD4+CD25+Foxp3+ regulatory T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Inducing and expanding regulatory T cell populations by foreign antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

TGF-beta regulates in vivo expansion of Foxp3-expressing CD4+CD25+ regulatory T cells responsible for protection against diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Cutting Edge: IL-2 is essential for TGF-beta-mediated induction of Foxp3+ T regulatory cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Role of LAG-3 in regulatory T cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Neuropilin-1: a surface marker of regulatory T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Galectin-1: a key effector of regulation mediated by CD4+CD25+ T cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Human CD4+CD25+ regulatory T cells: proteome analysis identifies galectin-10 as a novel marker essential for their anergy and suppressive function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Control of immune responses by antigen-specific regulatory T cells expressing the folate receptor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Control of regulatory T cell development by the transcription factor Foxp3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

An essential role for Scurfin in CD4+CD25+ T regulatory cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

CD4+CD25high regulatory cells in human peripheral blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

CD49d provides access to "untouched" human Foxp3+ Treg free of contaminating effector cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Isolation of functional human regulatory T cells (Treg) from the peripheral blood based on the CD39 expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

A function for interleukin 2 in Foxp3-expressing regulatory T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Regulatory T cell lineage specification by the forkhead transcription factor foxp3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Developmental regulation of Foxp3 expression during ontogeny.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Role of regulatory T cells in human diseases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Foxp3 occupancy and regulation of key target genes during T-cell stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Foxp3 interacts with nuclear factor of activated T cells and NF-kappa B to repress cytokine gene expression and effector functions of T helper cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

FOXP3 controls regulatory T cell function through cooperation with NFAT

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Impaired T cell receptor signaling in Foxp3+ CD4 T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Cutting edge: TGF-beta-induced expression of Foxp3 in T cells is mediated through inactivation of ERK.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Murine CD4+CD25+ regulatory T cells fail to undergo chromatin remodeling across the proximal promoter region of the IL-2 gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Distinct IL-2 receptor signaling pattern in CD4+CD25+ regulatory T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Altered proximal T cell receptor (TCR) signaling in human CD4+CD25+ regulatory T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Defective activation of protein kinase C and Ras-ERK pathways limits IL-2 production and proliferation by CD4+CD25+ regulatory T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

CD4+CD25+ T regulatory cells suppress NK cell-mediated immunotherapy of cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Cutting edge: direct suppression of B cells by CD4+ CD25+ regulatory T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

CCR6 expression defines regulatory effector/memory-like cells within the CD25(+)CD4+ T-cell subset.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Interleukin 2 signaling is required for CD4(+) regulatory T cell function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Cutting edge: IL-2 is critically required for the in vitro activation of CD4+CD25+ T cell suppressor function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

The Foxp3+ regulatory T cell: a jack of all trades, master of regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

CD4(+)CD25(+) T cells facilitate the induction of T cell anergy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Human CD4+CD25+ regulatory cells have marked and sustained effects on CD8+ T cell activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

CD4+ regulatory T cells require CTLA-4 for the maintenance of systemic tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Human T regulatory cells can use the perforin pathway to cause autologous target cell death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Cutting edge: contact-mediated suppression by CD4+CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

CD4+CD25+ regulatory T cells down-regulate co-stimulatory molecules on antigen-presenting cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Cutting edge: human CD4+CD25+ T cells restrain the maturation and antigen-presenting function of dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Modulation of dendritic cell function by naive and regulatory CD4+ T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Dendritic cells prohibited by anergic T cells acquire tolerogenic properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

The indoleamine 2,3-dioxygenase pathway is essential for human plasmacytoid dendritic cell-induced adaptive T regulatory cell generation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Regulatory T cells inhibit stable contacts between CD4+ T cells and dendritic cells in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Infectious tolerance: human CD25(+) regulatory T cells convey suppressor activity to conventional CD4(+) T helper cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

CD4+ CD25+ [corrected] regulatory T cells render naive CD4+ CD25- T cells anergic and suppressive

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Engagement of glucocorticoid-induced TNFR family-related receptor on effector T cells by its ligand mediates resistance to suppression by CD4+CD25+ T cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Regulation of immune cells by local-tissue oxygen tension: HIF1 alpha and adenosine receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Cellular distribution and functions of P2 receptor subtypes in different systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Alerting and tuning the immune response by extracellular nucleotides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

CD39 modulates IL-1 release from activated endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

P2Y(6) nucleotide receptor mediates monocyte interleukin-8 production in response to UDP or lipopolysaccharide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Extracellular ATP induces a distorted maturation of dendritic cells and inhibits their capacity to initiate Th1 responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Inflammasome adaptors and sensors: intracellular regulators of infection and inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

From inflammasomes to fevers, crystals and hypertension: how basic research explains inflammatory diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Extracellular ATP triggers and maintains asthmatic airway inflammation by activating dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Identification and characterization of CD39/vascular ATP diphosphohydrolase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

The E-NTPDase family of ectonucleotidases: Structure function relationships and pathophysiological significance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Ecto-enzyme and signaling functions of lymphocyte CD73

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Adenosine A2a receptors induce heterologous desensitization of chemokine receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Activation of Th1 and Tc1 cell adenosine A2A receptors directly inhibits IL-2 secretion in vitro and IL-2-driven expansion in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

T regulatory cells: hypoxia-adenosinergic suppression and re-direction of the immune response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Palmitoylation targets CD39/endothelial ATP diphosphohydrolase to caveolae.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

High sensitivity of CD4+CD25+ regulatory T cells to extracellular metabolites nicotinamide adenine dinucleotide and ATP: a role for P2X7 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

T regulatory and primed uncommitted CD4 T cells express CD73, which suppresses effector CD4 T cells by converting 5'-adenosine monophosphate to adenosine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Blocking the immune response in ischemic acute kidney injury: the role of adenosine 2A agonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Cyclic adenosine monophosphate is a key component of regulatory T cell-mediated suppression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Regulatory T cell-mediated suppression: potential role of ICER.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

ICER/CREM-mediated transcriptional attenuation of IL-2 and its role in suppression by regulatory T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

CD39 and control of cellular immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Developmental stage, phenotype, and migration distinguish naive- and effector/memory-like CD4+ regulatory T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Critical Influence of Natural Regulatory CD25+ T Cells on the Fate of Allografts in the Absence of Immunosuppression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

The balance of deletion and regulation in allograft tolerance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

IL-10 Is Required for Regulatory T Cells to Mediate Tolerance to Alloantigens In Vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Regulatory T cells in transplantation tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

The complementary roles of deletion and regulation in transplantation tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Regulatory T cells, derived from naïve CD4+CD25- T cells by in vitro Foxp3 gene transfer, can induce transplantation tolerance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

The generation of CD25+ CD4+ regulatory T cells that prevent allograft rejection does not compromise immunity to a viral pathogen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Regulatory T cells and organ transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Low circulating regulatory T-cell levels after acute rejection in liver transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Regulatory CD25+ T cells in human kidney transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Identification of a peripheral blood transcriptional biomarker panel associated with operational renal allograft tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Contrasting CD25hiCD4+T cells/FOXP3 patterns in chronic rejection and operational drug-free tolerance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Direct expansion of functional CD25+ CD4+ regulatory T cells by antigen-processing dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Human cd25(+)cd4(+) t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

In vitro-expanded human CD4(+)CD25(+) T-regulatory cells can markedly inhibit allogeneic dendritic cell-stimulated MLR cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Large-scale in vitro expansion of polyclonal human CD4(+)CD25high regulatory T cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Lymphopenia and interleukin-2 therapy alter homeostasis of CD4+CD25+ regulatory T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Ex vivo-expanded CD4+CD25+ immunoregulatory T cells prevent graft-versus-host-disease by inhibiting activation/differentiation of pathogenic T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Pancreatic lymph node-derived CD4(+)CD25(+) Treg cells: highly potent regulators of diabetes that require TRANCE-RANK signals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Protection against autoimmunity in nonlymphopenic hosts by CD4+ CD25+ regulatory T cells is antigen-specific and requires IL-10 and TGF-beta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Therapeutic vaccination using CD4+CD25+ antigen-specific regulatory T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Induction of allopeptide-specific human CD4+CD25+ regulatory T cells ex vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Generation and expansion of human CD4+ CD25+ regulatory T cells with indirect allospecificity: Potential reagents to promote donor-specific transplantation tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

In vitro-expanded donor alloantigen-specific CD4+CD25+ regulatory T cells promote experimental transplantation tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

In-vitro generation and characterisation of murine CD4+CD25+ regulatory T cells with indirect allospecificity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Expansion of functional endogenous antigen-specific CD4+CD25+ regulatory T cells from nonobese diabetic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Identification of regulatory T cells in tolerated allografts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

The role of peripheral T-cell deletion in transplantation tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Conferring indirect allospecificity on CD4+CD25+ Tregs by TCR gene transfer favors transplantation tolerance in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Influence of direct and indirect allorecognition pathways on CD4+CD25+ regulatory T-cell function in transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3+ regulatory T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

What does the future hold for cell-based tolerogenic therapy?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Two functional subsets of FOXP3+ regulatory T cells in human thymus and periphery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Heterogeneity of natural Foxp3+ T cells: a committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Identification of the immunophilins capable of mediating inhibition of signal transduction by cyclosporin A and FK506: roles of calcineurin binding and cellular location

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

The influence of immunosuppressive drugs on tolerance induction through bone marrow transplantation with costimulation blockade

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Differential effects of cyclosporine A, methylprednisolone, mycophenolate, and rapamycin on CD154 induction and requirement for NFkappaB: implications for tolerance induction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Combined costimulation blockade plus rapamycin but not cyclosporine produces permanent engraftment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Molecular mechanisms underlying FOXP3 induction in human T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Calcineurin inhibitors, but not rapamycin, reduce percentages of CD4+CD25+FOXP3+ regulatory T cells in renal transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Rapamune® (RAPA, rapamycin, sirolimus): mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Effects of immunosuppressants on induction of regulatory cells after intratracheal delivery of alloantigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Regulatory T cells induced by 1 alpha,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

CD4+CD25+ regulatory T cells in transplantation: progress, challenges and prospects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Favorably tipping the balance between cytopathic and regulatory T cells to create transplantation tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Clinical-grade preparation of human natural regulatory T-cells encoding the thymidine kinase suicide gene as a safety gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Selective survival of naturally occurring human CD4+CD25+Foxp3+ regulatory T cells cultured with rapamycin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Rapamycin monotherapy in patients with type 1 diabetes modifies CD4+CD25+FOXP3+ regulatory T-cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Fc-dependent depletion of activated T cells occurs through CD40L-specific antibody rather than costimulation blockade.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Rapamycin-mediated enrichment of T cells with regulatory activity in stimulated CD4+ T cell cultures is not due to the selective expansion of naturally occurring regulatory T cells but to the induction of regulatory functions in conventional CD4+ T

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Rapamycin does not induce anergy but inhibits expansion and differentiation of alloreactive human T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Rapamycin induces transforming growth factor-beta production by lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Contrasting effects of cyclosporine and rapamycin in de novo generation of alloantigen-specific regulatory T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Rational development of LEA29Y (belatacept), a high-affinity variant of CTLA4-Ig with potent immunosuppressive properties.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Absence of CD4CD25 regulatory T cell expansion in renal transplanted patients treated in vivo with Belatacept mediated CD28-CD80/86 blockade

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Following anti-CD25 treatment, a functional CD4+CD25+ regulatory T-cell pool is present in renal transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Anti-CD25 treatment and FOXP3-positive regulatory T cells in heart transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Alemtuzumab induction in kidney transplantation: clinical results and impact on T-regulatory cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

CD4+ CD25+ FOXP3+ regulatory T cells increase de novo in kidney transplant patients after immunodepletion with Campath-1H.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002

Rabbit ATG but not horse ATG promotes expansion of functional CD4+CD25highFOXP3+ regulatory T cells in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2010.01.002